ABOUT
The Value & Innovation Forum helps patients, providers and other health system stakeholders address timely, complex issues by conducting briefings that present a variety of perspectives. A June 2, 2020 briefing covered the uptake and pricing of biosimilars, and delivery system practices that may impact them.
SPEAKERS
- John M. Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention
- Nicole Braccio, PharmD, Policy Director, National Patient Advocate Foundation
- Christine Simmon, J.D., Senior Vice President, Policy & Strategic Alliances, Executive Director, Biosimilars Council, Association for Accessible Medicines
- Sarah Yim, MD, Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
- Chad Pettit, Executive Director, Global Value Access and Policy, Amgen
- Madelaine A. Feldman, MD, Practicing Rheumatologist, President, Coalition of State Rheumatology Organizations
|
|
To view the briefing playback, click here.
|
||
|
